DBIBB is a LPA2 receptor-specific nonlipid agonist. It acts by mitigating cell and tissue injury in vitro and in vivo, protecting cells from radiation injury and enhancing DNA repair via LPA2. References:

纯度：≥98%

CAS：1569309-92-7